The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity
Open accessAbstract
DNA methylation is an epigenetic process involved in embryonic development, differentiation and aging. It is 1 of the mechanisms resulting in gene silencing in carcinogenesis, especially in tumor suppressor genes (e.g., p16, Rb). Telomerase, the DNA polymerase adding TTAGGG repeats to the chromosome end, is involved in the regulation of the replicative life span by maintaining telomere length. This enzyme is activated in germ and stem cells, repressed in normal somatic cells and reactivated in a large majority of tumor cells. The promoter region of the hTERT gene, encoding for the catalytic subunit of human telomerase, has been located in a CpG island and may therefore be regulated at least in part by DNA methylation. We analyzed the methylation status of 27 CpG sites within the hTERT promoter core region by methylation‐sensitive single‐strand conformation analysis (MS‐SSCA) and direct sequencing using bisulfite‐modified DNA in 56 human tumor cell lines, as well as tumor and normal tissues from different organs. A positive correlation was observed among hypermethylation of the hTERT promoter, hTERT mRNA expression and telomerase activity (p < 0.00001). Furthermore, this correlation was confirmed in normal tissues where hypermethylation of the hTERT promoter was found exclusively in hTERT‐expressing telomerase‐positive samples and was absent in telomerase‐negative samples (p < 0.00002). Since tumor tissues contain also nonneoplastic stromal elements, we performed microdissection to allow confirmation that the hTERT promoter methylation truly occurred in tumor cells. Our results suggest that methylation may be involved in the regulation of hTERT gene expression. To our knowledge, this is the first gene in which methylation of its promoter sequence has been found to be positively correlated with gene expression. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a strong correlation between hTERT expression and TA, and recent studies have linked hTERT promoter hypermethylation to CRC and other cancer types [206].”
From Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy (2024) · cites this paper as [206]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,634
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,791
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
Baylln, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., & Issa, J. J. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60702-2 · Cited by 1,919
MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin
Nan, X., Campoy, F. J., & Bird, A. P. (1997) · Cell · doi:10.1016/s0092-8674(00)81887-5 · Cited by 1,288
Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M. M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-498 · Cited by 975
The essentials of DNA methylation
Bird, A. (1992) · Cell · doi:10.1016/0092-8674(92)90526-i · Cited by 948
Direct activation of TERT transcription by c-MYC
Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R. (1999) · Nature Genetics · doi:10.1038/6010 · Cited by 893
Telomere maintenance by recombination in human cells
Dunham, M. A., Neumann, A. A., Fasching, C. L., & Reddel, R. R. (2000) · Nature Genetics · doi:10.1038/82586 · Cited by 879
DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein
Boyes, J., & Bird, A. P. (1991) · Cell · doi:10.1016/0092-8674(91)90267-3 · Cited by 733
High levels of De Novo methylation and altered chromatin structure at CpG islands in cell lines
Antequera, F., Boyes, J., & Bird, A. P. (1990) · Cell · doi:10.1016/0092-8674(90)90015-7 · Cited by 696
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 260
Azouz, A., Wu, Y.-L., Hillion, J., Tárkányi, I., Karniguian, A., Aradi, J., Lanotte, M., Chen, G.-Q., Chehna, M. F., & Ségal-Bendirdjian, E. (2010) · Leukemia · doi:10.1038/leu.2009.283 · Cited by 39
Karslı-Çeppioğlu, S., Ngollo, M., Adjakly, M., Dagdemir, A., Judes, G., Lebert, A., Boiteux, J., Penault-Llorca, F. M., Bignon, Y., Guy, L., et al. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2014.0142 · Cited by 32
Zhang, Y., Wang, A., Wu, Q., Sheng, H., & Jin, Y. (2010) · Journal of Animal and Veterinary Advances · doi:10.3923/javaa.2010.2738.2747 · Cited by 32
Schütze, D. M., Kooter, J. M., Wilting, S. M., Meijer, C. J. L. M., Quint, W. G. V., Snijders, P. J. F., & Steenbergen, R. D. M. (2015) · Epigenetics · doi:10.4161/15592294.2014.990787 · Cited by 31
PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells
Bougel, S., Renaud, S., Braunschweig, R., Loukinov, D. I., Morse, H. C., Bosman, F. T., Lobanenkov, V. V., & Benhattar, J. (2009) · The Journal of Pathology · doi:10.1002/path.2620 · Cited by 31
Self-citationTelomerase Activation in Hematological Malignancies
Ropio, J., Merlio, J., Soares, P., & Chevret, E. (2016) · Genes · doi:10.3390/genes7090061 · Cited by 31
Miyake, Y., Adachi, J.-I., Suzuki, T., Mishima, K., Araki, R., Mizuno, R., & Nishikawa, R. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03016-8 · Cited by 31
Borssén, M., Cullman, I., Norén‐Nyström, U., Sundström, C., Porwit‐MacDonald, A., Forestier, E., & Roos, G. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.08.014 · Cited by 30
Pettigrew, K. A., Armstrong, R. N., Colyer, H. A. A., Zhang, S., Rea, I. M., Jones, R. E., Baird, D. M., & Mills, K. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.21962 · Cited by 31
Yim, H. W., Slebos, R. J. C., Randell, S. H., Umbach, D. M., Parsons, A. M., Rivera, M. P., Detterbeck, F. C., & Taylor, J. A. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.01.023 · Cited by 30
Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4
Zhang, N., Xie, Y., Tai, Y., Gao, Y., Guo, W., Yu, W., Li, J., Xu, F., Hao, J., Gao, Y., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000453206 · Cited by 29
Wang, Z., Xu, J., Geng, X., & Zhang, W. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2009.11.001 · Cited by 28
Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells
Love, W. K., Berletch, J. B., Andrews, L., & Tollefsbol, T. O. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.625 · Cited by 28
Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers
Losi, L., Fonda, S., Saponaro, S., Chelbi, S. T., Lancellotti, C., Gozzi, G., Alberti, L., Fabbiani, L., Botticelli, L., & Benhattar, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061559 · Cited by 28
Self-citationHansen, N., Wylie, R. C., Phipps, S. M. O., Love, W. K., Andrews, L., & Tollefsbol, T. O. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.3.641 · Cited by 28
A non-genetic, epigenetic-like mechanism of telomere length inheritance?
Meyer, T. D., Vandepitte, K., Denil, S. L. I. J., Buyzere, M. D., Rietzschel, E. R., & Bekaert, S. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.255 · Cited by 28
Epidemiology and Pathogenesis of Myelodysplastic Syndrome
Rotter, L. K., Shimony, S. O., Ling, K., Chen, E., Shallis, R. M., Zeidan, A. M., & Stahl, M. F. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000665 · Cited by 27
Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML / MDS
Zhao, X., Tian, X., Kajigaya, S., Cantilena, C. R., Strickland, S. A., Savani, B. N., Mohan, S. R., Feng, X., Keyvanfar, K., Dunavin, N., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14244 · Cited by 27
Telomerase regulation in hematological cancers: A matter of stemness?
Deville, L., Hillion, J., & Ségal-Bendirdjian, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.016 · Cited by 27
Blackberry Extract Inhibits Telomerase Activity in Human Colorectal Cancer Cells
Tatar, M., Bagheri, Z., Varedi, M., & Naghibalhossaini, F. (2018) · Nutrition and Cancer · doi:10.1080/01635581.2018.1506491 · Cited by 28
TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker
Liu, L., Liu, C., Fotouhi, O., Fan, Y., Wang, K., Xia, C., Shi, B., Zhang, G., Wang, K., Kong, F., et al. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0064 · Cited by 25
Establishment and Evaluation of a Stable Cattle Type II Alveolar Epithelial Cell Line
Su, F., Liu, X., Liu, G., Yu, Y., Wang, Y., Jin, Y., Hu, G., Song, H., & Zhang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076036 · Cited by 25
Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells
Walter, K., Rodríguez-Aznar, E., Ferreira, M. S. V., Frappart, P., Dittrich, T., Tiwary, K., Meessen, S., Lerma, L., Daiß, N., Schulte, L.-A., et al. (2021) · Cancers · doi:10.3390/cancers13133145 · Cited by 24
Panero, J., Stanganelli, C., Arbelbide, J. A., Fantl, D. B. E., Kohan, D., Rivello, H. G., Rabinovich, G. A., & Slavutsky, I. R. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.10.002 · Cited by 25
The molecular basis of ageing in stem cells
Tam, W. L., Ang, Y.-S., & Lim, B. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.020 · Cited by 25
Targeted gene therapy for breast cancer with truncated Bid
Kazhdan, I., Long, L. M., Montellano, R., Cavazos, D., & Marciniak, R. A. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700867 · Cited by 24
Kovalenko, T. F., Morozova, K. V., Pavlyukov, M. S., Anufrieva, K. S., Bobrov, M. Y., Gamisonia, A. M., Ozolinya, L. A., Dobrokhotova, Y. E., Shakhparonov, M. I., & Patrushev, L. I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0243093 · Cited by 22
Barger, C. J., Suwala, A. K., Soczek, K. M., Wang, A., Kim, M. Y., Hong, C., Doudna, J. A., Chang, S. M., Phillips, J. J., Solomon, D. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33099-x · Cited by 23
Establishment and evaluation of a stable steroidogenic caprine luteal cell line
Li, W., Xu, X., Huang, Y., Li, Z., Yu, G., Wang, Z., Ding, L., & Tong, D. (2012) · Theriogenology · doi:10.1016/j.theriogenology.2012.01.009 · Cited by 23
Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer
Chiacchiarini, M., Trocchianesi, S., Besharat, Z. M., Pò, A., & Ferretti, E. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107708 · Cited by 23
Sui, X., Kong, N., Wang, Z., & Pan, H. (2013) · Oncology Letters · doi:10.3892/ol.2013.1367 · Cited by 23
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
Esopi, D., Graham, M. K., Brosnan‐Cashman, J. A., Meyers, J. L., Vaghasia, A. M., Gupta, A. K., Kumar, B., Haffner, M. C., Heaphy, C. M., Marzo, A. M. D., et al. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00531-7 · Cited by 23
Li, M., Chen, S., CHEN, C., Zhang, Z.-X., Dai, M., ZHANG, L.-B., WANG, S.-B., Dai, Q., & Tao, Z. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3287 · Cited by 22
Phipps, S. M. O., Love, W. K., White, T. J., Andrews, L. G., & Tollefsbol, T. O. (2009) · PubMed · Cited by 21
Exploring hTERT promoter methylation in cutaneous T‐cell lymphomas
Chebly, A., Ropio, J., Péloponèse, J., Poglio, S., Prochazkova‐Carlotti, M., Cherrier, F., Ferrer, J., Idrissi, Y., Segal‐Bendirdjian, E., Chouery, É., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12946 · Cited by 20
Tarazón, E., Bustos, B. D. U., Estal, R. M., Pérez-Simó, G., Sahuquillo‐Torralba, A., Simarro, J., Suela, S. P., & Estrada, R. B. (2021) · Genes · doi:10.3390/genes12121931 · Cited by 20
Losi, L., Lauriola, A., Tazzioli, E., Gozzi, G., Scurani, L., D’Arca, D., & Benhattar, J. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0536-y · Cited by 19
Self-citationOikonomou, P., Messinis, I. E., & Tsezou, A. (2007) · PubMed · Cited by 19
Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review)
Liu, Y., Li, N., Wang, M., Yan-hua, Z., Yan, L.-D., Zhou, W., Yu, Z.-Q., Peng, X., & Cai, J. (2021) · Oncology Reports · doi:10.3892/or.2021.8133 · Cited by 18
Tianshengyuan-1 (TSY-1) regulates cellular Telomerase activity by methylation of TERT promoter
Yu, W., Qin, X., Jin, Y., Li, Y., Santiskulvong, C., Vu, V., Zeng, G., Zhang, Z., Chow, M., & Rao, J. (2016) · Oncotarget · doi:10.18632/oncotarget.13939 · Cited by 18
Masui, K., Komori, T., Kato, Y., Masutomi, K., Ichimura, K., Ogasawara, S., Kaneko, M. K., Oki, H., Suzuki, H., Nitta, M., et al. (2018) · BioMed Research International · doi:10.1155/2018/7945845 · Cited by 18
Wu, Y., Li, G., He, D., Yang, F., He, G., He, L., Zhang, H., Deng, Y., Fan, M., Shen, L., et al. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s97899 · Cited by 18
Cheng, D., Zhao, Y., Wang, S., Zhang, F., Russo, M., McMahon, S. B., & Zhu, J. (2016) · The FASEB Journal · doi:10.1096/fj.201601111r · Cited by 18
THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
Apolónio, J. D., Dias, J. S., Fernandes, M. T., Komosa, M., Lipman, T., Zhang, C. H., Leao, R. R. N., Lee, D., Nunes, N. M., Maia, A.-T., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01396-3 · Cited by 19
Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics
Melicher, D., Buzás, E. I., & Falus, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1991-2 · Cited by 17
Hsu, C.-C., Chen, C.-H., Hsu, T., Hung, J., Ko, J., Zhang, B., Lee, Y., Chen, H.-K., Chang, W., & Lin, D.-Y. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.12.004 · Cited by 17
Locus-Specific DNA Methylation Editing in Melanoma Cell Lines Using a CRISPR-Based System
Smith, J., Banerjee, R., Waly, R., Urbano, A., Gimenez, G., Day, R. C., Eccles, M. R., Weeks, R. J., & Chatterjee, A. (2021) · Cancers · doi:10.3390/cancers13215433 · Cited by 19
Lee, S., Borah, S., & Bahrami, A. (2017) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.01.003 · Cited by 18
Byun, Y., Choi, Y.-C., Jeong, Y., Yoon, J., & Baek, K. (2020) · Molecules and Cells · doi:10.14348/molcells.2020.0126 · Cited by 16
Palmqvist, R., Zhang, A., Xu, D., Golovleva, I., Norrback, K., Gruber, A., Öberg, Å., Stenling, R., & Roos, G. (2005) · International Journal of Cancer · doi:10.1002/ijc.21020 · Cited by 16
Atri, S., Nasoohi, N., & Hodjat, M. (2020) · Current Molecular Pharmacology · doi:10.2174/1874467213666200512080122 · Cited by 15
Telomere Maintenance in Pediatric Cancer
Ackermann, S., & Fischer, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235836 · Cited by 15
Establishment and evaluation of a stable steroidogenic goat Leydig cell line
Zhou, J., Dai, R., Lei, L., Lin, P., Lu, X., Wang, X., Tang, K., Wang, A., & Jin, Y. (2015) · Animal Science Journal · doi:10.1111/asj.12454 · Cited by 14
Moreno‐Acosta, P., Molano, M., MORALES, N., Acosta, J., González-Prieto, C., Mayorga, D., Buitrago, L., Gamboa, Ó., Mejía, J. C., Castro, J. D. M., et al. (2020) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20218 · Cited by 14
Targeting Telomere Biology in Acute Lymphoblastic Leukemia
Karow, A., Haubitz, M., Leibundgut, E. O., Helsen, I., Preising, N., Steiner, D., Dantonello, T. M., Ammann, R. A., Roessler, J., Kartal‐Kaess, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136653 · Cited by 14
Wang, S., Zhao, Y., Leiby, M. A., & Zhu, J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp511 · Cited by 14
Telomeres and telomerase in the clinical management of colorectal cancer
Piñol-Felis, C., Fernández-Marcelo, T., Viñas-Salas, J., & Valls-Bautista, C. (2017) · Clinical and Translational Oncology · doi:10.1007/s12094-016-1559-0 · Cited by 13
Prognostic value and immune landscapes of TERT promoter methylation in triple negative breast cancer
Lin, F., Huang, J., Zhu, W., Jiang, T., Guo, J., Xia, W., Chen, M., Guo, L., Deng, W., & Lin, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1218987 · Cited by 13
Li, S., Hu, G., Chen, Y., Sang, Y., Tang, Q., & Liu, R. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03459-2 · Cited by 15
Molano, M., Moreno‐Acosta, P., MORALES, N., Burgos, M., Buitrago, L., Gamboa, Ó., ALVAREZ, R., Garland, S. M., Tabrizi, S. N., Steenbergen, R. D. M., et al. (2016) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20011 · Cited by 13
Basic science: Epigenetic programming and the respiratory system
Durham, A. L., & Adcock, I. M. (2013) · Breathe · doi:10.1183/20734735.000413 · Cited by 12
hTERT methylation is necessary but not sufficient for telomerase activity in colorectal cells
Valls, C., Bougel, S., Piñol, C., Salas, J. V., & Benhattar, J. (2011) · Oncology Letters · doi:10.3892/ol.2011.386 · Cited by 12
Self-citationLi, J., Zheng, P. C. J.-R., & Wang, Y.-Z. (2017) · World Journal of Surgical Oncology · doi:10.1186/s12957-017-1170-z · Cited by 12
Metabolic stress induces modifications in the epigenetic program of preimplantation bovine embryos
Tremblay, R., Dufort, I., & Sirard, M. (2017) · Molecular Reproduction and Development · doi:10.1002/mrd.22941 · Cited by 14
Methylation profiling of mesothelioma using real‐time methylation‐specific PCR: A pilot study
Pu, R. T., Sheng, Z., Michael, C. W., Rhode, M. G., Clark, D. P., & O’Leary, T. J. (2007) · Diagnostic Cytopathology · doi:10.1002/dc.20692 · Cited by 12
Haraguchi, K., Yada, N., Sato, S., Habu, M., Hayakawa, M., Takahashi, O., Sasaguri, M., Takenaka, S., Yoshioka, I., Matsuo, K., et al. (2017) · Apmis · doi:10.1111/apm.12723 · Cited by 12
ALV Integration-Associated Hypomethylation at the TERT Promoter Locus
Lam, G., & BEEMON, K. L. (2018) · Viruses · doi:10.3390/v10020074 · Cited by 11
Targeting oncogenic TERT promoter variants by allele-specific epigenome editing
Kouroukli, A. G., Rajaram, N., Bashtrykov, P., Kretzmer, H., Siebert, R., Jeltsch, A., & Bens, S. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01599-2 · Cited by 11
Li, S., Huang, W., Li, Y., Chen, B., & Li, D. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s274743 · Cited by 11
Wang, Z., Guo, D., Yang, B., Wang, J., Wang, R., Wang, X.-W., & Zhang, Q.-Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110288 · Cited by 12
Sobecka, A., Błaszczak, W., Barczak, W., Golusiński, P., Rubiś, B., Masternak, M. M., Suchorska, W. M., & Golusiński, W. (2018) · Journal of Applied Genetics · doi:10.1007/s13353-018-0458-1 · Cited by 10
Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators
Rauscher, S., Greil, R., & Geisberger, R. (2021) · Current Cancer Drug Targets · doi:10.2174/1568009620666210108102723 · Cited by 10
Differential Expression of Epigenetic Modulators During Human Embryonic Stem Cell Differentiation
Phipps, S. M. O., Love, W. K., Mott, T. E., Andrews, L. G., & Tollefsbol, T. O. (2008) · Molecular Biotechnology · doi:10.1007/s12033-008-9118-8 · Cited by 10
Hill, C., Duffy, S., Coulter, T., Maxwell, A. P., & McKnight, A. J. (2023) · Genes · doi:10.3390/genes14030609 · Cited by 9
Epigenetic regulation of telomerase expression in HIV-1-specific CD8+ T cells
Williams, K. L., Seiss, K., Beamon, J., Pereyra, F., Rosenberg, E. S., Walker, B. D., Yu, X. G., & Lichterfeld, M. D. (2010) · AIDS · doi:10.1097/qad.0b013e32833c7170 · Cited by 9
Dietary Phytochemicals, Epigenetics, and Colon Cancer Chemoprevention
Arya, R., & Saldanha, S. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812494-9.00010-x · Cited by 9
Garsuault, D., Bouyer, C., Nguyen, É., Kandhari, R., Prochazkova‐Carlotti, M., Chevret, E., Forgez, P., & Ségal‐Bendirdjian, E. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12681 · Cited by 10
Xie, X., Pang, M., Shan, L., Yu, L., Zhao, Y., Ma, K., Kalhoro, D. H., Lu, C., & Liu, Y. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6794-8 · Cited by 9
Nguyen, É., Richerolle, A., Sánchez-Bellver, J., Varennes, J., & Ségal-Bendirdjian, E. (2022) · Biomedicines · doi:10.3390/biomedicines10030695 · Cited by 9
Lee, S., Chang, T., Schreiner, P. A., Fan, Y., Agarwal, N., Owens, C. R., Dummer, R., Kirkwood, J. M., Barnhill, R. L., Theodorescu, D., et al. (2022) · Cancers · doi:10.3390/cancers14164018 · Cited by 8
Li, Z., Ying, Y., Zeng, X., Liu, J., Xie, Y., Deng, Z., Hu, Z., & Yang, J. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01293-3 · Cited by 8
Budak, M., & Yıldız, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.78125 · Cited by 8
Canonical and non-canonical functions of the non-coding RNA component (TERC) of telomerase complex
Cao, C., Gong, W., Shuai, Y., Rasouli, S., Ge, Q., Anam Qadir, K. H. A. N., Dakic, A., Putluri, N., Shvets, G. B., Zheng, Y., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01367-0 · Cited by 8
TERT Promoter Methylation Is Oxygen-Sensitive and Regulates Telomerase Activity
Doğan, F., & Forsyth, N. R. (2024) · Biomolecules · doi:10.3390/biom14010131 · Cited by 7
Telomere maintenance mechanisms in neuroblastoma: New insights and translational implications
Werr, L., Rosswog, C., Bartenhagen, C., George, S. L., & Fischer, M. (2024) · EJC Paediatric Oncology · doi:10.1016/j.ejcped.2024.100156 · Cited by 7
Aberrant methylation of the TERT promoter in esophageal squamous cell carcinoma
Deng, J., Zhou, D., Zhang, J., Chen, Y., Wang, C., Liu, Y., & Zhao, K. (2015) · Cancer Genetics · doi:10.1016/j.cancergen.2015.10.004 · Cited by 9
Guo, N., Cheng, D., Li, Z. H., Zhou, Q., Zhou, J., Lin, Q., Zeng, B., Liao, Q., & Chen, R. F. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24218 · Cited by 7
External factors affecting fertility, and how to correct their impact.
Comhaire, F., Berghe, W. V., & Decleer, W. (2017) · Europe PMC (PubMed Central) · Cited by 7
Age-related Changes in DNA Methylation Status of hTERT Gene Promoter of Oral Epithelial Cells
Bezerra, S. F. D. O., Costa, L. D. A., de Freitas, P. A. N., & de Oliveira, N. F. P. (2014) · Brazilian Archives of Biology and Technology · doi:10.1590/s1516-8913201400029 · Cited by 7
Xie, R., Tuo, B., Yang, S., Chen, X., & Xu, J. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02226-4 · Cited by 6
pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma
Blanco-García, L., Ruano, Y., Martínez-Illescas, R. B., Martínez, R. C., Sánchez, P. J., Lobo, V. J. S.-A., Riveiro‐Falkenbach, E., Ortiz-Romero, P. L., Garrido, M. C., & Rodríguez‐Peralto, J. L. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18953 · Cited by 6
Xie, Y., Zhao, X., Jia, H., & Ma, B. (2012) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-012-9554-4 · Cited by 6
Ott, P., Araúzo-Bravo, M. J., Hoffmann, M. J., Poyet, C., Bendhack, M. L., Santourlidis, S., & Erichsen, L. (2022) · Cancers · doi:10.3390/cancers14184384 · Cited by 7
Saldanha, S. N., & Watanabe, L. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800957-4.00018-7 · Cited by 6
Epigenetic Alterations: The Relation Between Occupational Exposure and Biological Effects in Humans
Kahl, V. F. S., Cappetta, M., & da Silva, J. (2019) · RNA technologies · doi:10.1007/978-3-030-14792-1_11 · Cited by 6
Possibilities and effects of telomerase activation
Kovalenko, N. A., Zhdanov, D. D., & Kovalenko, T. F. (2013) · Molecular Biology · doi:10.1134/s0026893313040079 · Cited by 6
Masood, S., ElGabry, E. A., Zhang, C., & Wang, Z. (2016) · Diagnostic Cytopathology · doi:10.1002/dc.23505 · Cited by 6
Banerjee, R., Ajithkumar, P., Keestra, N., Smith, J., Gimenez, G., Rodger, E. J., Eccles, M. R., Antony, J., Weeks, R. J., & Chatterjee, A. (2024) · Cancers · doi:10.3390/cancers16050898 · Cited by 5
Santourlidis, S., Araúzo-Bravo, M. J., Brodell, R. T., Hassan, M., & Bendhack, M. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137331 · Cited by 5
Targeting Telomerase in Hematologic Malignancy
Maritz, M. F., Napier, C. E., Wen, V. W., & MacKenzie, K. L. (2010) · Future Oncology · doi:10.2217/fon.10.42 · Cited by 5
Metadata
- Authors
- Guilleret, I., Yan, P., Grange, F., Braunschweig, R., Bosman, F. T., & Benhattar, J.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Benhattar, Jean
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2002-08-29
- Volume
- 101
- Issue
- 4
- Pages
- 335-341
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2055902044
- Cited by
- 260
- References
- 44
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 10 · 2023: 13 · 2022: 12 · 2021: 12 · 2020: 18 · 2019: 13 · 2018: 12 · 2017: 12 · 2016: 19 · 2015: 18 · 2014: 5 · 2013: 12 · 2012: 8
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- hTERT, telomerase, promoter hypermethylation, DNA methylation, CpG islands, telomerase activity, gene expression regulation, tumor suppressor, gene silencing, cancer cell lines, telomere length
- MeSH terms
- DNA-Binding Proteins, Humans, Neoplasms, Promoter Regions, Genetic, RNA, Messenger, Tumor Cells, Cultured, Gene Expression Regulation, Enzymologic, Polymorphism, Single-Stranded Conformational, Telomerase, DNA Methylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review